Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Potential First-in-Class, Oral Treatment for a Condition Affecting an Estimated 26 Million U.S. Women(1)
If Approved, First Oral Therapy to Demonstrate Efficacy and Safety for Uterine Fibroids in Two U.S. Pivotal Studies
DUBLIN, Oct. 10, 2017 -- (Hea... Biopharmaceuticals, FDA Allergan, ulipristal, uterine fibroids
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news